Lineage Announces FDA Clearance of IND Amendment for OPC1 Ce

The DOSED Clinical Study Will Evaluate a Novel Delivery Device in Subacute and Chronic Spinal Cord Injury Patients

...

Related Keywords

California , United States , American , Brianm Culley , , California Institute For Regenerative Medicine Under Proposition , Twitter , International Spinal Cord Injury Pain Questionnaire , California Institute For Regenerative Medicine , Roche Group , Drug Administration , Exchange Commission , Genentech , California Stem Cell Agency , International Spinal Cord Injury Pain Basic Data , Lineage Cell Therapeutics Inc , Lineage Cell Therapeutics , Investigational New Drug , Oligodendrocyte Progenitor Cells , Spinal Cord Injury , Novel Device , California Institute , Regenerative Medicine , International Standards , Neurological Classification , Regenerative Medicine Advanced Therapy , Orphan Drug , Stem Cell Agency , Cell Therapeutics , Annual Report , Markets ,